Doximity Inc (DOCS)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $5.95B
Last updated: Nov 17, 2026 at 11:03 AM ET
Doximity Inc (DOCS) Earnings: Report Dates and Results
Doximity (DOCS) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Doximity reported EPS of $0.19, in line with the $0.19 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DOCS has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 4.3% below the $0.46 reported for the quarter ended Dec 31, 2025.
DOCS Earnings Call
The latest DOCS earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 22 quarters below that had an estimate, DOCS beat 19, missed 2 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $174.54M, up 3.6% from $168.53M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.19 | $0.19 | N/A | 0.00% | In line | -57.8% | 18 | 0 up, 1 down | Nov 5, 2026 | $174.54M |
| Jun 30, 2026 | $0.14 | $0.16 | N/A | -12.50% | Miss | -48.1% | 18 | 0 up, 13 down | Aug 6, 2026 | $156.62M |
| Mar 31, 2026 | $0.26 | $0.28 | $0.22 - $0.33 | -7.14% | Miss | -18.8% | 19 | 0 up, 17 down | May 13, 2026 | $145.37M |
| Dec 31, 2025 | $0.46 | $0.45 | $0.37 - $0.48 | +2.22% | Beat | +2.2% | 19 | 3 up, 5 down | Feb 5, 2026 | $185.05M |
| Sep 30, 2025 | $0.45 | $0.38 | $0.33 - $0.41 | +18.42% | Beat | +50.0% | 17 | 2 up, 0 down | Nov 6, 2025 | $168.53M |
| Jun 30, 2025 | $0.27 | $0.24 | N/A | +12.50% | Beat | -3.6% | 16 | 4 up, 6 down | Aug 7, 2025 | $145.91M |
| Mar 31, 2025 | $0.32 | $0.20 | N/A | +60.00% | Beat | +28.0% | 17 | 14 up, 0 down | May 15, 2025 | $138.29M |
| Dec 31, 2024 | $0.45 | $0.34 | $0.32 - $0.35 | +32.35% | Beat | +55.2% | 14 | 13 up, 0 down | Feb 6, 2025 | $168.60M |
| Sep 30, 2024 | $0.30 | $0.26 | $0.23 - $0.27 | +15.38% | Beat | +36.4% | 14 | 1 up, 0 down | Nov 7, 2024 | $136.83M |
| Jun 30, 2024 | $0.28 | $0.23 | $0.20 - $0.24 | +21.74% | Beat | +47.4% | 15 | 0 up, 0 down | Aug 8, 2024 | $126.68M |
| Mar 31, 2024 | $0.25 | $0.20 | $0.14 - $0.22 | +25.00% | Beat | +25.0% | 15 | 1 up, 0 down | May 16, 2024 | $118.06M |
| Dec 31, 2023 | $0.29 | $0.24 | $0.16 - $0.25 | +20.83% | Beat | +31.8% | 12 | 0 up, 0 down | Feb 8, 2024 | $135.28M |
| Sep 30, 2023 | $0.22 | $0.18 | $0.16 - $0.20 | +22.22% | Beat | +29.4% | 9 | 0 up, 0 down | Nov 9, 2023 | $113.61M |
| Jun 30, 2023 | $0.19 | $0.15 | $0.12 - $0.17 | +26.67% | Beat | +35.7% | 10 | 0 up, 0 down | Aug 8, 2023 | $108.47M |
| Mar 31, 2023 | $0.20 | $0.17 | $0.16 - $0.19 | +17.65% | Beat | -4.8% | 10 | 0 up, 0 down | May 16, 2023 | $110.97M |
| Dec 31, 2022 | $0.22 | $0.17 | $0.16 - $0.20 | +29.41% | Beat | -24.1% | 9 | 0 up, 0 down | Feb 9, 2023 | $115.26M |
| Sep 30, 2022 | $0.17 | $0.16 | $0.14 - $0.18 | +6.25% | Beat | -10.5% | 11 | 0 up, 0 down | Nov 10, 2022 | $102.19M |
| Jun 30, 2022 | $0.14 | $0.11 | $0.07 - $0.12 | +27.27% | Beat | +27.3% | 9 | 0 up, 1 down | Aug 4, 2022 | $90.64M |
| Mar 31, 2022 | $0.21 | $0.15 | $0.12 - $0.23 | +40.00% | Beat | +250.0% | 9 | 0 up, 0 down | May 17, 2022 | $93.65M |
| Dec 31, 2021 | $0.29 | $0.12 | $0.11 - $0.19 | +141.67% | Beat | N/A | 8 | 0 up, 0 down | Feb 8, 2022 | $97.88M |
| Sep 30, 2021 | $0.19 | $0.09 | $0.09 - $0.11 | +111.11% | Beat | -56.7% | 6 | N/A | Nov 9, 2021 | $79.35M |
| Jun 30, 2021 | $0.11 | $0.08 | $0.06 - $0.10 | +37.50% | Beat | N/A | 6 | N/A | Aug 10, 2021 | $72.67M |
| Mar 31, 2021 | $0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 25, 2021 | $66.69M |
| Dec 31, 2020 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | $58.71M |
| Sep 30, 2020 | $0.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2020 | $45.11M |
| Dec 31, 2019 | -$0.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | $32.43M |
Annual EPS
EPS for the fiscal year ended Mar 31, 2026 was $1.44, up 6.7% from the year before. It was $0.08 for the year ended Mar 31, 2021, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Mar 31, 2026 | $1.44 | +6.7% |
| Mar 31, 2025 | $1.35 | +42.1% |
| Mar 31, 2024 | $0.95 | +30.1% |
| Mar 31, 2023 | $0.73 | -8.8% |
| Mar 31, 2022 | $0.80 | +939.0% |
| Mar 31, 2021 | $0.08 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,700 words across 17 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,689 | 17 | |
| 2026Q2 | Jun 30, 2026 | 8,648 | 20 | |
| 2026Q1 | Mar 31, 2026 | 8,455 | 18 | |
| 2025Q4 | Dec 31, 2025 | 8,651 | 18 | |
| 2025Q3 | Sep 30, 2025 | 9,167 | 23 | |
| 2025Q2 | Jun 30, 2025 | 8,083 | 17 | |
| 2025Q1 | Mar 31, 2025 | 8,035 | 20 | |
| 2024Q4 | Dec 31, 2024 | 5,036 | 9 |
2026Q3 Earnings Call
Opening remarks
Perry Gold VP of Investor Relations Thank you, operator. Hello, and welcome to Doximity's fiscal 2026 third quarter earnings call. With me on the call today are Jeffrey Tangney, Co-Founder and CEO of Doximity, and audit committee chair and board member, Tim Cabral, who is stepping in to help out with our CFO, Anna Bryson, currently on medical leave. A complete disclosure of our results can be found in our press release issued earlier today as well as in our related Form 8-K. Along with a copy of our prepared remarks, all available on our website at investors.doximity.com. As a reminder, today's call is being recorded and a replay will be available on our website. As part of our comments today, we will be making forward-looking statements. These statements are based on management's current views, expectations, and assumptions and are subject to various risks and uncertainties. Actual results may differ materially, and we disclaim any obligation to update any forward-looking statements or outlook. Please refer to the risk factors in our annual report on Form 10-K, any subsequent Form 10-Qs, and our other reports and filings with the SEC that may be filed from time to time, including our upcoming filing on Form 10-Q. Our forward-looking statements are based on assumptions that we believe to be reasonable as of today's date, February 5, 2026. Of note, it is Doximity's policy to neither reiterate nor adjust the financial guidance provided on today's call unless it is also done through a public disclosure such as a press release or through the filing of a Form 8-K. Today, we will discuss certain non-GAAP metrics that we believe aid in the understanding of our financial results. A historical reconciliation to comparable GAAP metrics can be found in today's earnings release. Finally, during the call, we may offer incremental metrics to provide greater insights into the dynamics of our business. These details may be one-time in nature, and we may or may not provide updates on those metrics in the future. I would now like to turn the call over to our co-founder and CEO, Jeffrey Tangney. Jeff?
Jeffrey Tangney Co-Founder & CEO Thanks, Perry, and thank you, everyone, for joining our third quarter earnings call. We have four updates today: our CFO, financials, network stats, and AI results. First, some unfortunate news. Our CFO, Anna Bryson, is out sick on medical leave. We miss her here at the office and wish her the best. I know she wishes she could be here too. We've been fortunate to have Tim Cabral, the former ten-year veteran CFO from Viva Systems, as our audit committee chair for the past five years.
Frequently Asked Questions About DOCS
When is Doximity's next earnings date?
Doximity's next earnings report is expected for Feb 3, 2027.
Did DOCS beat earnings estimates last quarter?
Doximity reported EPS of $0.19 for the quarter ended Sep 30, 2026, in line with the $0.19 estimate.
What EPS do analysts expect from DOCS next quarter?
The consensus EPS estimate for Doximity for the quarter ending Dec 31, 2026 is $0.44 from 17 analysts, with estimates from $0.39 to $0.51.
How often does DOCS beat earnings estimates?
Doximity beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +13.23%.
DOCS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts